Anti-TNF-alpha-induced anti-phospholipid syndrome manifested as necrotizing vasculitis.
作者信息
Vereckei Edit, Kriván G, Réti M, Szodoray P, Poór G, Kiss E
出版信息
Scand J Rheumatol. 2010 Mar;39(2):175-7. doi: 10.3109/03009740902832753.
PMID:20337548
Abstract
摘要
相似文献
1
Anti-TNF-alpha-induced anti-phospholipid syndrome manifested as necrotizing vasculitis.抗TNF-α诱导的抗磷脂综合征表现为坏死性血管炎。
Scand J Rheumatol. 2010 Mar;39(2):175-7. doi: 10.3109/03009740902832753.
2
Arterial thrombosis with anti-phospholipid antibodies induced by infliximab.
Eur J Dermatol. 2007 Nov-Dec;17(6):546-7. doi: 10.1684/ejd.2007.0280. Epub 2007 Oct 19.
3
Tumor necrosis factor-alpha blockade and the risk of vasculitis.肿瘤坏死因子-α阻断与血管炎风险
J Rheumatol. 2004 Oct;31(10):1885-7.
4
Nephrotic syndrome associated with anti-tumor necrosis factor alpha therapy in a patient with rheumatoid arthritis: comment on the article by Charles et al.
Arthritis Rheum. 2002 Jun;46(6):1691-3; author reply 1693. doi: 10.1002/art.10344.
5
Should anti-tumor necrosis factor-alpha be the first therapy for rheumatoid vasculitis?抗肿瘤坏死因子-α应该作为类风湿性血管炎的首选治疗方法吗？
J Rheumatol. 2006 Feb;33(2):433; author reply 433-4.
6
Comparison of anti-TNF alpha autoantibodies in plasma and from EBV transformed lymphocytes of autoimmune and normal individuals.自身免疫个体和正常个体血浆及EB病毒转化淋巴细胞中抗TNFα自身抗体的比较。
Hum Antibodies Hybridomas. 1995;6(2):73-6.
7
Anti-TNF-alpha-induced systemic lupus syndrome.抗肿瘤坏死因子-α诱导的系统性红斑狼疮综合征。
Clin Rheumatol. 2003 Feb;22(1):56-61. doi: 10.1007/s10067-002-0654-5.
8
TNF-alpha-targeted therapy in rheumatoid arthritis.类风湿关节炎中的肿瘤坏死因子-α靶向治疗
Rev Rhum Engl Ed. 1999 Apr;66(4):187-91.
9
Sensory neuropathy revealing necrotizing vasculitis during infliximab therapy for rheumatoid arthritis.在类风湿关节炎英夫利昔单抗治疗期间出现坏死性血管炎的感觉神经病变。
J Rheumatol. 2004 Oct;31(10):2079-81.
10
Anti-TNF-induced lupus.抗TNF诱导的狼疮。
Rheumatology (Oxford). 2009 Jul;48(7):716-20. doi: 10.1093/rheumatology/kep080. Epub 2009 May 4.
引用本文的文献
1
Stroke in SARS-CoV-2 Infection: A Pictorial Overview of the Pathoetiology.2019冠状病毒病感染中的中风：病理病因学的图示概述
Front Cardiovasc Med. 2021 Mar 29;8:649922. doi: 10.3389/fcvm.2021.649922. eCollection 2021.
2
Digital ischaemia secondary to adalimumab-induced antiphospholipid syndrome.阿达木单抗诱导的抗磷脂综合征继发的手指缺血
BMJ Case Rep. 2020 Feb 9;13(2):e232907. doi: 10.1136/bcr-2019-232907.
3
Thromboembolic complications in inflammatory bowel disease.炎症性肠病中的血栓栓塞并发症
J Thromb Thrombolysis. 2015 May;39(4):489-98. doi: 10.1007/s11239-014-1129-7.
4
Antiphospholipid antibodies during 6-month treatment with infliximab: a preliminary report.英夫利昔单抗治疗6个月期间的抗磷脂抗体：初步报告。
Med Sci Monit. 2014 Jul 16;20:1227-31. doi: 10.12659/MSM.890270.
5
Venous thrombosis and prothrombotic factors in inflammatory bowel disease.炎症性肠病中的静脉血栓形成与血栓前状态因素
World J Gastroenterol. 2014 May 7;20(17):4857-72. doi: 10.3748/wjg.v20.i17.4857.
6
Adalimumab-associated antiphospholipid syndrome: a case report and review of the literature.阿达木单抗相关抗磷脂综合征：病例报告及文献复习。
Clin Rheumatol. 2013 Jul;32(7):1095-8. doi: 10.1007/s10067-013-2244-0. Epub 2013 Apr 5.
7
Drug-induced lupus anticoagulants and antiphospholipid antibodies.药物诱导性狼疮抗凝物和抗磷脂抗体。
Curr Rheumatol Rep. 2012 Feb;14(1):71-8. doi: 10.1007/s11926-011-0227-1.
Zotero 插件